Brought to you by:
‘Historical’ CREST-2 data show reduced stroke risk with carotid stenting versus medical therapy alone
The international CREST-2 study has found that, for people with severe carotid artery narrowing who have not experienced recent stroke symptoms, a minimally invasive carotid artery stenting (CAS) procedure—combined with intensive medical therapy—significantly lowered stroke risk compared with medical therapy…
First patient enrolled in InspireMD’s CGUARDIANS II pivotal study
InspireMD today announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluating its CGuard Prime carotid stent system in patients undergoing carotid artery stenting (CAS) via the transcarotid artery revascularisation (TCAR) approach. The patient was…
Contego Medical’s Neuroguard IEP system receives US FDA approval for carotid revascularisation
Contego Medical today announced the US Food and Drug Administration’s (FDA) premarket approval (PMA) of the Neuroguard IEP system for carotid revascularisation. The company shares in a press release that clinical studies of the Neuroguard IEP system, including the PERFORMANCE…
InspireMD receives IDE approval from FDA for CGUARDIANS II pivotal trial
InspireMD has announced that the Food and Drug Administration (FDA) approval of the company’s investigational device exemption (IDE) application to initiate the CGUARDIANS II pivotal study of its CGuard Prime 80cm carotid stent system during transcarotid artery revascularization (TCAR) procedures.…
SVS Vascular Quality Initiative launches Carotid Care Quality Champion program
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry today announced the Carotid Care Quality Champion recognition program. The program honors healthcare organizations across the USA dedicated to improving the safety and effectiveness of vascular care through participation…
Data and discussion forefront carotid session at ‘pivotal moment’
Contemporary management of carotid disease after the Centers for Medicare and Medicaid Services (CMS) carotid artery stenting (CAS) decision memo and prior to CREST-2 results will be the focus of an Education Session at VAM 2024. In October, CMS released…
CEA associated with less reintervention than stenting in first six months-study
A durability study that looks at reintervention risk among patients treated with carotid endarterectomy (CEA) versus carotid artery stenting (CAS) procedures established that CEA demonstrated the lowest risk up to six months after surgery. A subgroup analysis between stenting procedures—transfemoral…
Vascular community split over ‘death’ of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider, MD, professor of vascular and endovascular surgery at University of California San Francisco in San Francisco, and Domenico Valenti, MD, professor of vascular surgery at King’s College London in London, England—on the…
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death risks—underpinning current Society for Vascular Surgery (SVS) guidelines recommending routine use of distal embolic protection during…
Equivalency to clinical practice ‘varies considerably’ across recent carotid intervention trials
The transferability to real-world clinical practice of contemporary randomized controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably,” according to a recent analysis published in the European Journal of Vascular and Endovascular Surgery (EJVES) by senior author Hans-Henning Eckstein,…